Literature DB >> 3781188

Hepatic uptake of sex steroids in men with alcoholic cirrhosis.

J Guechot, M Vaubourdolle, F Ballet, J Giboudeau, F Darnis, R Poupon.   

Abstract

We attempted to determine to what extent the degree of liver function impairment might affect the hepatic uptake and, as a consequence, alter the systemic plasma levels of endogenous sex steroids in male patients with alcoholic cirrhosis. The plasma levels and hepatic uptake of the steroids dehydroepiandrosterone, androstenedione, testosterone, dihydrotestosterone, estrone, estradiol, progesterone, and 17-hydroxyprogesterone were assessed. Systemic plasma levels of testosterone and dehydroepiandrosterone were significantly (p less than 0.05) reduced, whereas those of androstenedione, estrone, and estradiol were significantly (p less than 0.05) elevated in men with alcoholic cirrhosis when compared to controls. Sex hormone binding globulin levels were also significantly elevated (p less than 0.01). The hepatic uptake of sex steroids depended on the degree of liver function impairment as shown by the linear significant relationship between their hepatic extractions and that of indocyanine green (r = 0.74-0.92, p less than 0.05; except for dihydrotestosterone, r = 0.17, not significant). In addition, the hepatic uptake of sex steroids depended on the binding affinity to sex hormone binding globulin. The higher the affinity for sex hormone binding globulin, the lower the hepatic uptake influenced by liver function impairment. It was estimated that hepatic clearances accounted for only 20%-50% of the metabolic clearance of sex steroids. No significant relationship between plasma levels of sex steroids and their hepatic clearance was found. We show here that in alcoholic cirrhosis the extent of hepatic uptake of sex steroids depends partly on the degree of liver function impairment and partly on the degree to which they are bound to sex hormone binding globulin. Production rate or peripheral metabolism, or both, rather than hepatic uptake alone may account for the altered circulating levels of sex steroids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3781188     DOI: 10.1016/0016-5085(87)90860-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

Review 1.  Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.

Authors:  F Hervé; S Urien; E Albengres; J C Duché; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

Review 2.  Male hypogonadism in cirrhosis and after liver transplantation.

Authors:  C Foresta; M Schipilliti; F A Ciarleglio; A Lenzi; D D'Amico
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

3.  Hematotesticular barrier is altered from early stages of liver cirrhosis: effect of insulin-like growth factor 1.

Authors:  Inma Castilla-Cortazar; Nieves Diez; Maria Garcia-Fernandez; Juan-Enrique Puche; Fernando Diez-Caballero; Jorge Quiroga; Matias Diaz-Sanchez; Alberto Castilla; Amelia-Diaz Casares; Isabel Varela-Nieto; Jesus Prieto; Salvador Gonzalez-Baron
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

4.  Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.

Authors:  Kristin Alexandra Dayton; Fernando Bril; Diana Barb; Jinping Lai; Srilaxmi Kalavalapalli; Kenneth Cusi
Journal:  PLoS One       Date:  2021-06-02       Impact factor: 3.240

5.  Major surgery induces acute changes in measured DNA methylation associated with immune response pathways.

Authors:  Ryoichi Sadahiro; Bridget Knight; Ffion James; Eilis Hannon; John Charity; Ian R Daniels; Joe Burrage; Olivia Knox; Bethany Crawford; Neil J Smart; Jonathan Mill
Journal:  Sci Rep       Date:  2020-04-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.